ASN-003

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameASN-003
Drug Alias NameASN-003
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitorsSerine/threonine-protein kinase B-raf inhibitors
TargetsPI3-kinase class ISerine/threonine-protein kinase B-raf
Therapy Area/IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsMelanoma +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAsana Biosciences Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAsana Biosciences Llc
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell LungColorectal NeoplasmsMelanoma +[4] 

Other Information

ATC CodeN/A
Related LinksN/A